Emotional processing in adults with intellectual developmental disorder

Assessing Emotional Processes in Adults With Intellectual Developmental Disorder Using the ACQUISS Battery

Not applicable Interventional Hôpital le Vinatier · NCT07303270

This project will test whether adults with intellectual developmental disorder have trouble recognizing emotions and whether those difficulties are linked to attention and eye-movement processes compared with adults without IDD.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment60 (estimated)
Ages18 Years to 35 Years
SexAll
SponsorHôpital le Vinatier Academic / other
Locations1 site (Bron)
Trial IDNCT07303270 on ClinicalTrials.gov

What this trial studies

The study compares emotional abilities of adults with intellectual developmental disorder to a healthy control group using a three-step protocol. Step 1 screens intellectual, auditory, and visual functioning using standardized tests. Step 2 uses neuropsychological tasks of attention and oculomotor control while a family member completes behavioral questionnaires. Step 3 applies the ACQUISS experimental tasks (faces, faces in context, and prosody) to link emotion recognition performance with attentional and eye-movement measures.

Who should consider this trial

Good fit: Adults aged 18–35 with a DSM-5 diagnosis of intellectual developmental disorder who are French-speaking, covered by social security, able to provide consent (or whose guardian consents), and have a caregiver available to complete questionnaires.

Not a fit: People with unstable epilepsy, significant uncorrected visual or auditory impairments, major motor disorders, pregnancy or breastfeeding, or those on treatments that strongly affect brain or psychological functioning are unlikely to benefit or to be eligible.

Why it matters

Potential benefit: If successful, the findings could help tailor behavioral interventions to improve social interactions and quality of life for adults with IDD.

How similar studies have performed: Previous research has documented emotion-recognition difficulties in people with intellectual disability and has used face and prosody tasks, so this approach builds on existing findings though adult-specific characterization remains limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

IDD group :

* Diagnosis of IDD according to DSM-V criteria
* aged between 18 and 3 years
* French speaking
* Membership or entitlement to a social security plan
* informed consent, or that of the tutor, to take part in the study
* presence of a caregiver to complete the questionnaires at V2.

Control group :

* aged between 18 and 35 years
* French speaking
* Membership or entitlement to a social security plan
* Informed written consent to take part in the study.

Exclusion Criteria:

IDD group :

* visual or auditory impairments, evaluated at V1
* non stabilized epilepsy
* undergoing treatments that can impact brain or psychological functioning
* major motor disorders
* breastfeeding or pregnant woman

Control group :

* neurodevelopmental or psychiatric disorder
* history of brain trauma (TBI, stroke, etc…) or non-stabilized epilepsy
* visual or auditory impairments, evaluated at V1
* non stabilized epilepsy
* undergoing treatments that can impact brain or psychological functioning
* major motor disorders
* breastfeeding or pregnant woman

Where this trial is running

Bron

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Intellectual Developmental Disorderemotional processingCognitive assessmentsSocial cognition
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.